title: Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits.
abstract: Citrate anticoagulation has risen in interest so it is now a real alternative to heparin in the ICUs practice. Citrate provides a regional anticoagulation virtually restricted to extracorporeal circuit, where it acts by chelating ionized calcium. This issue is particularly true in patients ongoing CRRT, when the "continuous" systemic anticoagulation treatment is per se a relevant risk of bleeding. When compared with heparin most of studies with citrate reported a longer circuit survival, a lower rate of bleeding complications, and transfused packed red cell requirements. As anticoagulant for CRRT, the infusion of citrate is prolonged and it could potentially have some adverse effects. When citrate is metabolized to bicarbonate, metabolic alkalosis may occur, or for impaired metabolism citrate accumulation leads to acidosis. However, large studies with dedicated machines have indeed demonstrated that citrate anticoagulation is well tolerated, safe, and an easy to handle even in septic shock critically ill patients.
authors: Department of Medicine Area, Nephrology and Dialysis Unit, CTO Hospital, Via G. Zuretti 29, Turin, Italy.
authors: Filippo
authors: F
authors: Mariano
authors: Daniela
authors: D
authors: Bergamo
authors: Ezio Nicola
authors: EN
authors: Gangemi
authors: Zsuzsanna
authors: Z
authors: Hollo'
authors: Maurizio
authors: M
authors: Stella
authors: Giorgio
authors: G
authors: Triolo
references: Blood Purif. 2004;22(3):313-9
references: 15256798
references: Am J Nephrol. 2002 Jan-Feb;22(1):29-34
references: 11919400
references: Am J Med Sci. 1961 Jul;242:32-43
references: 13772690
references: Intensive Care Med. 2010 Oct;36(10):1735-43
references: 20480135
references: Am J Kidney Dis. 2005 Nov;46(5):903-7
references: 16253731
references: Kidney Int. 1999 May;55(5):1991-7
references: 10231464
references: Am J Kidney Dis. 1994 Nov;24(5):806-12
references: 7977323
references: Crit Care Med. 2001 Apr;29(4):748-52
references: 11373461
references: Nephrol Dial Transplant. 2011 Jan;26(1):232-9
references: 20876598
references: J Nephrol. 2011 Mar-Apr;24(2):165-76
references: 20586025
references: Crit Care Med. 2003 Oct;31(10):2450-5
references: 14530750
references: Nephrol Dial Transplant. 2005 Jul;20(7):1416-21
references: 15855212
references: Am J Kidney Dis. 2006 Nov;48(5):806-11
references: 17060000
references: J Nephrol. 2007 Sep-Oct;20(5):602-8
references: 17918147
references: Crit Care Med. 2009 Feb;37(2):545-52
references: 19114912
references: Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87
references: 17699194
references: J Am Soc Nephrol. 1996 Jan;7(1):145-50
references: 8808122
references: Kidney Int. 2005 Jun;67(6):2361-7
references: 15882280
references: J Crit Care. 2003 Jun;18(2):121-9
references: 12800123
references: Nephrol Dial Transplant. 2004 Jan;19(1):171-8
references: 14671053
references: Crit Care Med. 2009 Jun;37(6):2018-24
references: 19384210
references: Kidney Int. 2001 Jul;60(1):370-4
references: 11422774
references: Intensive Care Med. 2002 Oct;28(10):1419-25
references: 12373466
references: Nephron Clin Pract. 2004;97(4):c131-6
references: 15331942
references: J Crit Care. 2005 Jun;20(2):155-61
references: 16139156
references: Crit Care Med. 2009 Feb;37(2):764-5
references: 19325378
references: Crit Care Med. 2002 Apr;30(4):900-3
references: 11940766
references: Kidney Int. 1990 Nov;38(5):976-81
references: 2266683
references: Intensive Care Med. 2004 Feb;30(2):260-265
references: 14600809